FDF

Perrigo API extends its Active Pharmaceutical Ingredients (APIs) product line with selected Finished Dosage Forms (FDFs) where it is strategically advantageous to customers, providing the most added value and differentiation for clients.

Perrigo API focuses on developing those FDFs which require complex and sophisticated manufacturing processes, providing our valuable clients with highly professional regulatory support and reliable supply chain.

All Perrigo API products, are made with high standards complying with GMP and regulatory requirements of leading health authorities.

Products under patent are not sold until patent expiration in the relevant country.

FDFTherapeutic UseMore
Anastrozole tablets 1 mgTreatment of hormone receptor-positive breast cancer in postmenopausal women
Cetirizine dihydrochloride 10 mg tablets Cetirizine dihydrochloride 10 mg/ml, oral drops Cetirizine dihydrochloride 1 mg/ml, oral solutionSymptomatic treatment of allergic rhinitis
Granisetron HCl ampoules 1 mg/ml 1ml, 3 mlPrevention and treatment of acute nausea and vomiting associated with chemotherapy and radiotherapy
Granisetron HCl tablets 1, 2 mgPrevention and treatment of acute nausea and vomiting associated with chemotherapy and radiotherapy
Letrozole tablets 2.5 mgFirst-line treatment in postmenopausal women with hormone-dependent breast cancer
Moxonidine tablets 0.2, 0.3, 0.4 mgMild to moderate essential hypertension
Temozolomide hard gelatin capsules 5, 20, 100, 140, 180, 250 mgTreatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma

Cookie Policy

By using our site you consent to the use of cookies in accordance with the terms of our privacy policy.

Hide this message
Perrigo on Facebook Perrigo on Twitter Perrigo on YouTube Perrigo on LinkedIn Perrigo RSS